- Home
- TKLF vs ADXN Comparison
TKLF vs ADXN Comparison
Compare TKLF & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKLF | ADXN |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | Japan | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 8.6M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TKLF | ADXN |
|---|---|---|
| Price | $2.19 | $5.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 45.7K | 3.3K |
| Earning Date | 12-19-2025 | 04-30-2026 |
| Dividend Yield | ★ 10.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $5.41 |
| 52 Week High | $4.32 | $12.05 |
Technical Indicators
Market Signals| Indicator | TKLF | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 47.15 |
| Support Level | $2.02 | $5.68 |
| Resistance Level | $2.43 | $7.37 |
| Average True Range (ATR) | 0.16 | 0.26 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 38.00 | 32.78 |
Price Performance
Historical ComparisonAbout TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.